| __timestamp | Amicus Therapeutics, Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 5699000000 |
| Thursday, January 1, 2015 | 47269000 | 5001000000 |
| Friday, January 1, 2016 | 71151000 | 5002000000 |
| Sunday, January 1, 2017 | 88671000 | 4849000000 |
| Monday, January 1, 2018 | 127200000 | 4551000000 |
| Tuesday, January 1, 2019 | 169861000 | 4871000000 |
| Wednesday, January 1, 2020 | 156407000 | 7661000000 |
| Friday, January 1, 2021 | 192710000 | 7690000000 |
| Saturday, January 1, 2022 | 213041000 | 7814000000 |
| Sunday, January 1, 2023 | 275270000 | 7772000000 |
| Monday, January 1, 2024 | 8414000000 |
Data in motion
In the ever-evolving pharmaceutical landscape, effective cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two industry players: Bristol-Myers Squibb Company and Amicus Therapeutics, Inc., from 2014 to 2023.
Bristol-Myers Squibb, a titan in the field, consistently reported SG&A expenses averaging around $6 billion annually. Notably, their expenses peaked in 2022, marking a 72% increase from their lowest point in 2018. In contrast, Amicus Therapeutics, a smaller yet dynamic entity, exhibited a steady upward trend, with expenses growing by over 1,200% from 2014 to 2023.
This stark contrast highlights the diverse strategies employed by pharmaceutical companies in managing operational costs. As the industry faces mounting pressures, understanding these financial dynamics becomes essential for stakeholders aiming to navigate the complexities of healthcare economics.
Eli Lilly and Company vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company or Zoetis Inc.: Who Manages SG&A Costs Better?
Bristol-Myers Squibb Company or Vertex Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Neurocrine Biosciences, Inc.
Bristol-Myers Squibb Company and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Bristol-Myers Squibb Company or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
GSK plc vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Alnylam Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Amicus Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.